Stockscreener 앱 받기
11.36
3.27%
0.36
시간 외 거래:
11.36
Envveno Medical Corp 주식(NVNO)의 최신 뉴스
NVNO Forecast — Price Target — Prediction for 2027 - TradingView
A42085 Forecast — Price Target — Prediction for 2027 - TradingView
enVVeno Medical receives U.S. patent for venous valve system By Investing.com - Investing.com Nigeria
enVVeno Medical receives U.S. patent for venous valve system - Investing.com
enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial - ACCESS Newswire
enVVeno patent covers key enVVe valve parts before pivotal FDA trial - Stock Titan
enVVeno Medical (NVNO) Gains 2.6% as Shares Test Key Resistance Near $11.67Ascending Triangle - dars.gov.et
Enterprise value to revenue forward of enVVeno Medical Corporation – NASDAQ:NVNO - TradingView
Price to sales forward of enVVeno Medical Corporation – NASDAQ:NVNO - TradingView
Price to sales forward of enVVeno Medical Corporation – FWB:5HJ0 - TradingView
Price to book forward of enVVeno Medical Corporation – NASDAQ:NVNO - TradingView
Price to earnings forward of enVVeno Medical Corporation – NASDAQ:NVNO - TradingView
Enterprise value to EBITDA forward of enVVeno Medical Corporation – NASDAQ:NVNO - TradingView
Price to book forward of enVVeno Medical Corporation – FWB:5HJ0 - TradingView
enVVeno Medical Corporation Actuals & Estimates (FWB:5HJ0) - TradingView
enVVeno Medical Corporation Actuals & Estimates (NASDAQ:NVNO) - TradingView
enVVeno Medical Corporation Actuals & Estimates (BOATS:NVNO) - TradingView
enVVeno Medical Corp (NVNO) Institutional Confidence - TradingKey
enVVeno Medical to Present in the Webull Corporate Connect Webinar Series - ACCESS Newswire
FDA-cleared venous valve study takes center stage at enVVeno webinar - Stock Titan
enVVeno Medical (NVNO) Dips 1.96%, Testing Support at $9.5Strong Buy Stocks - dars.gov.et
enVVeno Medical Corp (NVNO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
enVVeno Medical Corp (NVNO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
enVVeno Medical Corp (NVNO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
enVVeno Medical Corp (NVNO) Valuation: PE, PB & Fair Value Analysis - TradingKey
enVVeno Medical Corp (NVNO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
enVVeno Medical Corp (NVNO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
enVVeno Medical Corp (NVNO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
enVVeno Medical Corp (NVNO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
enVVeno Medical (NVNO) Retreats 1.96% as Stock Navigates Key Support at $9.50Value Stock Ideas - newsline.com
Insider Selling: Francis Duhay Sells Shares of enVVeno Medical C - GuruFocus
Director at enVVeno Medical (NASDAQ: NVNO) sells 140 shares under Rule 10b5-1 plan - Stock Titan
[144] enVVeno Medical Corp SEC Filing - Stock Titan
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System - PhillyBurbs
enVVeno Medical Announces Reverse Stock Split - Great Falls Tribune
enVVeno Medical (NVNO) Holds Steady at $10.75 – Support and Resistance Define Neutral RangeUndervalued Stocks - newsline.com
enVVeno Medical to Participate in the Virtual Investor Closing Bell Series - ACCESS Newswire
EnVVeno Medical to Participate in the Virtual Investor Closing Bell Series - marketscreener.com
PMI Stock Price and Chart — AMEX:PMI - TradingView
NVNO Q3 2025 Earnings: Narrower-than-Expected Loss Drives Positive Stock ReactionMargin Expansion Trends - newsline.com
enVVeno Medical (NVNO) Edges Higher as Stock Tests Key Resistance Near $11.90Throwback Trade - The Legal Advocate
enVVeno Medical (NVNO) Edges Lower as Stock Holds Above Key SupportFRAMA Signal - newsline.com
enVVeno Medical (NVNO) Slips 1.03% as Price Hovers Near Key Support at $10.47Factor Crowding - newsline.com
NVNO Q3 2025 Earnings: Narrower Net Loss Surpasses Analyst ExpectationsEarnings Season Review - The Legal Advocate
This Tiny Medical-Device Stock Is Back Above $11. Its Next FDA Test Is the Whole Trade - Bez Kabli
NVNOenVVeno Medical Corp Stock Price and Quote - Finviz
enVVeno Medical Q3 2025 Earnings: Narrower Loss Beats Expectations as Clinical Programs AdvanceProfit Margin Analysis - The Legal Advocate
enVVeno Medical (NVNO) Q3 2025 Earnings: Narrower-Than-Expected Loss Signals Cost Discipline Progress - newsline.com
enVVeno Medical (NVNO) Edges Higher: Analyzing Recent Price Action and Key LevelsWave Truncation - Newser
Perceptive entities disclose 9.99% stake in enVVeno (NASDAQ: NVNO) - Stock Titan
This Medical Device Stock Just Plunged A Whopping 71% Today – Do You Own It? - MSN
Kingdon group holds 36,166 shares in enVVeno (NASDAQ: NVNO) - Stock Titan
Number of shareholders of enVVeno Medical Corporation – NASDAQ:NVNO - TradingView
enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment - The Joplin Globe
2.36%
자본화:
|
볼륨(24시간):